Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013

News provided by

May 07, 2013, 02:11 ET

NEW YORK, May 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0829619/Lennox-Gastaut-Syndrome-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Summary

GlobalData's clinical trial report, "Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2013" provides data on the Lennox-Gastaut Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lennox-Gastaut Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lennox-Gastaut Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Lennox-Gastaut Syndrome 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by BRIC Nations 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by E7 Nations 16
Clinical Trials in E7 Nations by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Lennox-Gastaut Syndrome 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Lennox-Gastaut Syndrome Therapeutics Clinical Trials 25
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
H. Lundbeck A/S 28
Clinical Trial Overview of H. Lundbeck A/S 28
Eisai Inc. 29
Clinical Trial Overview of Eisai Inc. 29
GlaxoSmithKline Ltd. 30
Clinical Trial Overview of GlaxoSmithKline Ltd. 30
GlaxoSmithKline LLC 31
Clinical Trial Overview of GlaxoSmithKline LLC 31
Janssen-Cilag A.G. 32
Clinical Trial Overview of Janssen-Cilag A.G. 32
Ajanta Pharma Limited 33
Clinical Trial Overview of Ajanta Pharma Limited 33
Lundbeck Inc. 34
Clinical Trial Overview of Lundbeck Inc. 34
Par Pharmaceutical Companies, Inc. 35
Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 35
Eisai Co., Ltd. 36
Clinical Trial Overview of Eisai Co., Ltd. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Clinical Trial Overview of Top Universities / Institutes / Hospitals 38
L'Institution de Lavigny 38
Clinical Trial Overview of L'Institution de Lavigny 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
Five Key Clinical Profiles 40
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables

Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 10
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2013* 11
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 12
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, BRIC Countries, 2013* 13
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, G7 Countries, 2013* 14
Lennox-Gastaut Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, E7 Countries, 2013* 16
Lennox-Gastaut Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 17
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2013* 18
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 19
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Lennox-Gastaut Syndrome Therapeutics Market, Global, Suspended Clinical Trials, 2013* 21
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 24
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 26
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 27
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013* 28
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2013* 29
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Ltd., 2013* 30
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline LLC, 2013* 31
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag A.G., 2013* 32
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajanta Pharma Limited, 2013* 33
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Lundbeck Inc., 2013* 34
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Par Pharmaceutical Companies, Inc., 2013* 35
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2013* 36
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 37
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by L'Institution de Lavigny, 2013* 38
Lennox-Gastaut Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 39

List of Figures

Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 10
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2013* 14
Lennox-Gastaut Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Lennox-Gastaut Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 17
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 18
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 19
Lennox-Gastaut Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 23
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 25
Lennox-Gastaut Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 27
GlobalData Methodology 76